Companies often underestimate the complexity of standing up an eQMS. These are five of the most common issues that lead to regulatory and GMP exposure risk.
- Proteomics Tools: A Resurrection
- Powering AI And Synthetic Biology In Therapy Design
- Six Specialized Modalities Testing CDMO Readiness In 2026
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Real Reason We Haven't Fully Automated Cell Therapy Yet
- Process Engineering's Key Role In Sterile Injectable Facility Design
- What To Know About — And How To Apply For — FDA's PreCheck Pilot
- Breaking Through Tumor Defenses With Next-Generation Cell Therapy
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Physiologix]( "Evaluate The Effects Of A Xeno-Free Serum Replacement Media Supplementation")
Evaluate The Effects Of A Xeno-Free Serum Replacement Media SupplementationThis study compares the impact of a specific Human Growth Factor Concentrate (hGFC) and fetal bovine serum (FBS) on the growth, expansion, and viability of MSCs.
-
![GettyImages-513110674 lab, research, sample, vial]( "Navigating CMC Regulation For Plasmid DNA In Gene Therapy")
Navigating CMC Regulation For Plasmid DNA In Gene TherapyExplore how evolving regulatory pathways and CMC innovation are shaping the future of gene therapy and viral vector production, plus what to consider when selecting a CDMO partner.
-
![GettyImages-1388184871-quality-compliance-approval]( "Review Of Applications And Processes In Fixed-Bed Bioreactors")
Review Of Applications And Processes In Fixed-Bed BioreactorsGain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.
-
![GettyImages-1455668983 Coronavirus cells]( "Revolutionizing Viral Infectious Disease Research And Drug Discovery")
Revolutionizing Viral Infectious Disease Research And Drug DiscoveryLearn how Organ-Chips are being used to rapidly identify promising treatments, investigate virus evolution, and analyze how mechanical forces influence the innate immune response to viral infections.
-
![GettyImages-1590452153-assay-well-plate-microcscope-image]( "Rapid Walkaway Solution For Assessing Viability In Cancer Organoids")
Rapid Walkaway Solution For Assessing Viability In Cancer OrganoidsAssess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.
-
![GettyImages-1388184871-quality-compliance-approval]( "Developing A Large-Scale Tangential Flow Filtration Process")
Developing A Large-Scale Tangential Flow Filtration ProcessDiscover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.
-
![GettyImages-2196144750 CAR-T Cell]( "Enabling The Rapid, Reproducible Manufacturing Of TranspoCART Cells")
Enabling The Rapid, Reproducible Manufacturing Of TranspoCART CellsLearn how an innovative technology streamlines Transpocart cell production, making rapid and consistent manufacturing a reality for cell therapies.
-
![GettyImages-171144953-cryopreservation-freeze]( "Small Volume ATMP Cryo-Freezing Strategies")
Small Volume ATMP Cryo-Freezing StrategiesDiscover best practices for cryopreserving small-volume ATMPs, focusing on sterility, viability, and efficiency with advanced containers and packaging.
-
![Cydem VT]( "A High-Throughput Platform For Fast And Reliable Clone Screening")
A High-Throughput Platform For Fast And Reliable Clone ScreeningThe Cydem VT platform consists of several technologies allowing for the cultivation and monitoring of CHO cells in cell line development. Find out how to set up your experiment on this device.
-
![GettyImages-1086892494-bacterial-colony-dish-microscopic]( "Fluorescent Bacterial Colony Selection")
Fluorescent Bacterial Colony SelectionFluorescent reporter genes simplify screening bacterial transformants. Discover a system that automates colony picking to enhance efficiency and precision with fluorescence imaging.
NEWSLETTER ARCHIVE
- 03.06.26 -- New Podcast Episodes: Therapeutic Power Of Fibroblasts, Curative Cell Therapies, Breakthrough HER2 Immunotherapy
- 03.06.26 -- Simplifying Friction In Cell Therapy Clinical Trials With Dr. Panteli Theocharous
- 03.05.26 -- Regulatory, Payer & Distribution Insights For CGT Success
- 03.05.26 -- Process Engineering's Key Role In Sterile Injectable Facility Design
- 03.04.26 -- Breaking Through Tumor Defenses With Next-Generation Cell Therapy
- Powering AI And Synthetic Biology In Therapy Design
- Inside Mesoblast's Playbook For Making Allogeneic Cell Therapy Real
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Global Shifts And Strategic Resilience Will Shape CGT In 2026
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
